skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders

Journal Article · · Journal of Medicinal Chemistry
 [1];  [1];  [1]; ORCiD logo [1]; ORCiD logo [2];  [3];  [4];  [4];  [4];  [5];  [6];  [7];  [8];  [9];  [10]; ORCiD logo [10];  [10];  [10];  [10]
  1. Tetra Discovery Partners, Inc., Grand Rapids, MI (United States)
  2. Northern Illinois Univ., DeKalb, IL (United States)
  3. Beryllium Discovery Corp., Bainbridge Island, WA (United States)
  4. State Univ. of New York (SUNY), Buffalo, NY (United States)
  5. West Virginia Univ., Morgantown, WV (United States). Rockefeller Neurosciences Inst.
  6. Univ. of Michigan, Ann Arbor, MI (United States)
  7. INDS Inc., Ann Arbor, MI (United States)
  8. White Global Pharma Consultants, 31 Kinglet Drive, South Cranbury, New Jersey 08512, United States
  9. Pharma-Vation Consulting, LLC, Chesterfield, MO (United States)
  10. Albany Molecular Research, Inc., Albany, NY (United States)

Novel pyridine- and pyrimidine-based allosteric inhibitors are reported that achieve PDE4D subtype selectivity through recognition of a single amino acid difference on a key regulatory domain, known as UCR2, that opens and closes over the catalytic site for cAMP hydrolysis. The design and optimization of lead compounds was based on iterative analysis of X-ray crystal structures combined with metabolite identification. Selectivity for the activated, dimeric form of PDE4D provided potent memory enhancing effects in a mouse model of novel object recognition with improved tolerability and reduced vascular toxicity over earlier PDE4 inhibitors that lack subtype selectivity. The lead compound, 28 (BPN14770), has entered midstage, human phase 2 clinical trials for the treatment of Fragile X Syndrome.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH)
Grant/Contract Number:
NS078034
OSTI ID:
1544866
Journal Information:
Journal of Medicinal Chemistry, Vol. 62, Issue 10; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 30 works
Citation information provided by
Web of Science

References (76)

Cyclic AMP Control Measured in Two Compartments in HEK293 Cells: Phosphodiesterase KM Is More Important than Phosphodiesterase Localization journal September 2011
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown journal February 2010
PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts journal April 2011
PKA Dynamics in a Drosophila Learning Center: Coincidence Detection by Rutabaga Adenylyl Cyclase and Spatial Regulation by Dunce Phosphodiesterase journal February 2010
A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. journal October 1993
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions journal April 2011
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety journal December 2009
Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4 journal March 2015
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase: INVOLVEMENT OF SERINE 54 IN THE ENZYME ACTIVATION journal July 1996
The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus journal February 2015
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model journal July 1998
PRKAR1A and PDE4D Mutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance journal December 2012
Exome Sequencing Identifies PDE4D Mutations in Acrodysostosis journal April 2012
Exome Sequencing Identifies PDE4D Mutations as Another Cause of Acrodysostosis journal April 2012
Identification of Novel Mutations Confirms Pde4d as a Major Gene Causing Acrodysostosis : HUMAN MUTATION journal November 2012
Different mutations in PDE4D associated with developmental disorders with mirror phenotypes journal November 2013
Phenotypic Variability in a Family with Acrodysostosis Type 2 Caused by a Novel PDE4D Mutation Affecting the Serine Target of Protein Kinase-A Phosphorylation journal December 2017
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer’s Disease journal November 2014
Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3 journal July 2017
Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets journal November 2017
Erratum: GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium journal September 2017
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence journal June 2018
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals journal July 2018
Genetic Association of Phosphodiesterases With Human Cognitive Performance journal February 2019
Defect in cyclic AMP phosphodiesterase due to the dunce mutation of learning in Drosophila melanogaster journal January 1981
dunce, a mutant of Drosophila deficient in learning journal May 1976
Molecular analysis of cDNA clones and the corresponding genomic coding sequences of the Drosophila dunce+ gene, the structural gene for cAMP phosphodiesterase. journal December 1986
Dynamics of Learning-Related cAMP Signaling and Stimulus Integration in the Drosophila Olfactory Pathway journal November 2009
The Drosophila learning and memory gene rutabaga encodes a Ca2+calmodulin-responsive adenylyl cyclase journal February 1992
Cognitive Neuroscience and the Study of Memory journal March 1998
Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein journal October 1994
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus journal April 1996
Regulation of Neurogenesis in Adult Mouse Hippocampus by cAMP and the cAMP Response Element-Binding Protein journal May 2002
Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons journal June 1993
Calcium-Stimulated Adenylyl Cyclase Activity Is Critical for Hippocampus-Dependent Long-Term Memory and Late Phase LTP journal August 1999
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors journal March 1983
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory journal December 1998
Amyloid  -peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling journal September 2002
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment journal December 2004
Reversal of long-term dendritic spine alterations in Alzheimer disease models journal September 2009
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling journal December 2015
Apremilast: A Review in Psoriasis and Psoriatic Arthritis journal July 2015
PDE4 inhibitors: current status: PDE4 inhibitors and respiratory disease journal October 2008
Roflumilast: A Review in COPD journal September 2015
The Toxicity of SCH 351591, a Novel Phosphodiesterase-4 Inhibitor, in Cynomolgus Monkeys journal April 2004
Investigation of the Molecular Mechanisms Preceding PDE4 Inhibitor-Induced Vasculopathy in Rats: Tissue Inhibitor of Metalloproteinase 1, a Potential Predictive Biomarker journal June 2007
Structural basis for the design of selective phosphodiesterase 4B inhibitors journal March 2014
Discovery of selective PDE4B inhibitors journal June 2009
Discovery of triazines as selective PDE4B versus PDE4D inhibitors journal August 2014
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases journal December 2004
Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs) journal August 2002
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use journal September 2006
Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice journal August 2018
PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway journal January 2001
Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis journal October 2002
Cyclic AMP metabolism in fragile X syndrome journal January 1992
Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome journal January 1993
Reduced Cyclic AMP Production in Fragile X Syndrome: Cytogenetic and Molecular Correlations journal November 1995
Advances in the Treatment of Fragile X Syndrome journal January 2009
Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain journal June 2002
Absence of expression of the FMR-1 gene in fragile X syndrome journal August 1991
The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System journal September 2007
PDE-4 Inhibition Rescues Aberrant Synaptic Plasticity in Drosophila and Mouse Models of Fragile X Syndrome journal January 2015
Learning and Memory Deficits Consequent to Reduction of the Fragile X Mental Retardation Protein Result from Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila journal September 2012
Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D) journal November 2017
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits journal May 1997
Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome journal October 2000
PDE4D regulates Spine Plasticity and Memory in the Retrosplenial Cortex journal March 2018
Enhanced Dendritic Compartmentalization in Human Cortical Neurons journal October 2018
XDS journal January 2010
Features and development of Coot journal March 2010
Overview of the CCP 4 suite and current developments journal March 2011
The Protein Data Bank journal January 2000
Announcing the worldwide Protein Data Bank journal December 2003
Repeated Methamphetamine Treatment Impairs Recognition Memory Through a Failure of Novelty-Induced ERK1/2 Activation in the Prefrontal Cortex of Mice journal January 2006
Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling journal January 2011

Cited By (4)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening journal January 2020
Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction journal January 2020
Protection from AmyloidβPeptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor journal September 2019
Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design journal February 2020